# NHLBI and Cook Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty (TRAIPTA) Early Feasibility Study

> clinical trial · VERIFIED · 2026-06-12

Status: SUSPENDED · Sponsor: National Heart, Lung, and Blood Institute (NHLBI) · Condition: Tricuspid Valve Insufficiency

- Company: National Heart, Lung, and Blood Institute (NHLBI)
- Sector: cardiology/medtech
- Primary source: https://clinicaltrials.gov/study/NCT06479824

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED.